NeuroTechR3 Inc.

NeuroTechR3 Inc. develops R3THA, an advanced neurorehabilitation platform designed for individuals recovering from stroke, cerebral palsy, and other neurological conditions. The system combines adaptive, machine learning-driven exergames with real-time biofeedback to enhance hand and arm function recovery. R3THA gamifies rehabilitation therapy, enabling patients to engage in interactive experiences both in clinical and home settings. The platform features remote progress tracking and therapist oversight capabilities to optimize patient adherence and motivation. Clinical evidence demonstrates 20% improvement in Box and Block Test (BBT), 13.6% improvement in Fugl-Meyer Assessment (FMA-UE), and 15.2% improvement in Action Research Arm Test (ARAT) over three months in individuals 6 months to 17 years post-stroke. The company is funded by the National Science Foundation (NSF), National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), Administration for Community Living (ACL), and New Jersey Economic Development Authority (NJEDA), indicating strong federal and state research support.